Send to

Choose Destination
Diabetes Ther. 2017 Oct;8(5):991-998. doi: 10.1007/s13300-017-0313-0. Epub 2017 Sep 16.

A Practical Approach to Managing Hypoactive Sexual Desire Disorder in Women with Diabetes.

Author information

Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, MD, USA.
Department of Pharmacy Practice, Wingate University School of Pharmacy, Wingate, NC, USA.


Female sexual dysfunction (FSD) is highly prevalent in women with diabetes mellitus (DM), yet it remains unaddressed, undiagnosed, and untreated. Hypoactive sexual desire disorder (HSDD) is the most common complaint among women with FSD, but there is a paucity of research into its multifactorial etiology. Flibanserin is the only therapy approved by the US Food and Drug Administration for treating acquired, generalized HSDD in premenopausal women. Women with DM diagnosed with HSDD may require a multidisciplinary approach for optimal management.


Diabetes mellitus (DM); Female sexual disorder (FSD); Flibanserin; Hypoactive sexual desire disorder (HSDD); Testosterone

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center